COMP <GO>
LICN vs ACCS // ENTERPRISE SCALE & MARKET CAP
Lichen International Limited (Class A) (NASDAQ) VS. ACCESS Newswire Inc. (NYSE) • 15-METRIC TALLY: LICN 3
— ACCS 5
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ACCS
LAST: $0.75 (-12.79%) • MKT CAP: $12.3M
market-cap
$12.3M
LAST: $3.75 (0.00%) • MKT CAP: $14.4M
market-cap
$14.4M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LICN VS. ACCS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LICN | ACCS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | 76.50% | +19.50 | LICN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.70% | -5.10% | -27.60 | ACCS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 3.75% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -8.30% | -51.70 | ACCS | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 19.00% | -79.00 | ACCS | /net-margins <GO> |
| Revenue Growth (YoY) | — | -1.90% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.57 | 1.28 | +0.29 | LICN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 6/9 | -3.00 | ACCS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 26.5 | 17.9 | +8.58 | LICN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $12.3M | $14.4M | -$2.0M | ACCS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LICN REV | ACCS REV | LICN GROSS % | ACCS GROSS % | LICN FCF | ACCS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $809.0K | $22.6M | 98.0% | 76.5% | -$17.8M | $538.0K |
| FY 2024 | $0 | $23.1M | — | 75.6% | -$5.6M | $3.1M |
| FY 2023 | $0 | $24.5M | — | — | $557.0K | $3.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LICN // BETA —
ACCS // BETA —